Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 (CLDI.WS)

CLDI.WS was delisted on the 17th of October, 2024.

• Market cap: $375K
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.

Employees: 41